James H. Mackaness, Chief Financial Officer at SOLENO THERAPEUTICS INC (SLNO), bought 11,235 shares at $0.89 ($10K) on 2021-09-13, disclosed to the SEC on 2021-09-14.
Open-market purchase of $10k SLNO by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |